Publication|Articles|November 16, 2026

Pharmacy Practice in Focus: Health Systems

  • November 2026
  • Volume 15
  • Issue 6

Semaglutide-Associated Sensory Skin Disturbance in Patients Without Diabetes Treated for Weight Loss

This case series describes 2 instances of cutaneous sensory disturbance during semaglutide therapy in patients without diabetes and discusses possible mechanisms as hypotheses requiring further investigation.

To describe suspected cutaneous sensory adverse drug reactions associated with semaglutide use for chronic weight management and to present hypothesis-generating mechanisms that warrant further study.

Related to this article